A Phase 1, Open-Label, 2-Period, Fixed Sequence Study to Estimate the Effect of Itraconazole on the Pharmacokinetics of PF-07817883 in Healthy Adults
Latest Information Update: 07 Oct 2024
At a glance
- Drugs Ibuzatrelvir (Primary) ; Itraconazole
- Indications COVID 2019 infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 24 Jul 2023 Status changed from active, no longer recruiting to completed.
- 28 Jun 2023 Planned End Date changed from 20 Jun 2023 to 10 Jul 2023.
- 28 Jun 2023 Planned primary completion date changed from 20 Jun 2023 to 10 Jul 2023.